|Articles|July 22, 2016
EMA Seeks to Revise Guidance on First-In-Human Trials
July 22, 2016
Advertisement
The European Medicines Agency (EMA) is proposing changes to the current guidelines on first-in-human clinical trials to improve risk-based strategies. This proposal was made with cooperation from the European Commission and the Member States of the European Union (EU).
Read the full release
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
3
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
4
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
5